These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8828547)

  • 21. Natural killer cells in vernal keratoconjunctivitis.
    Lambiase A; Normando EM; Vitiello L; Micera A; Sacchetti M; Perrella E; Racioppi L; Bonini S; Bonini S
    Mol Vis; 2007 Aug; 13():1562-7. PubMed ID: 17893656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conjunctival deposition of eosinophil granule major basic protein in vernal keratoconjunctivitis and contact lens-associated giant papillary conjunctivitis.
    Trocme SD; Kephart GM; Allansmith MR; Bourne WM; Gleich GJ
    Am J Ophthalmol; 1989 Jul; 108(1):57-63. PubMed ID: 2750834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporin A inhibits eosinophilic infiltration into the conjunctiva mediated by type IV allergic reactions.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Liu FT; Ueno H
    Clin Exp Ophthalmol; 2006; 34(4):347-53. PubMed ID: 16764655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allergic chronic inflammation of the ocular surface in vernal keratoconjunctivitis.
    Bonini S; Lambiase A; Sgrulletta R; Bonini S
    Curr Opin Allergy Clin Immunol; 2003 Oct; 3(5):381-7. PubMed ID: 14501439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current Knowledge in Allergic Conjunctivitis.
    Villegas BV; Benitez-Del-Castillo JM
    Turk J Ophthalmol; 2021 Feb; 51(1):45-54. PubMed ID: 33631915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated levels of substance P in tears of patients with allergic conjunctivitis and vernal keratoconjunctivitis.
    Fujishima H; Takeyama M; Takeuchi T; Saito I; Tsubota K
    Clin Exp Allergy; 1997 Apr; 27(4):372-8. PubMed ID: 9146929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. M cells are involved in pathogenesis of human contact lens-associated giant papillary conjunctivitis.
    Zhong X; Liu H; Pu A; Xia X; Zhou X
    Arch Immunol Ther Exp (Warsz); 2007; 55(3):173-7. PubMed ID: 17557145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical therapy for ocular allergy.
    Trocme SD; Raizman MB; Bartley GB
    Mayo Clin Proc; 1992 Jun; 67(6):557-65. PubMed ID: 1359206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mast cell distribution and neutral protease expression in acute and chronic allergic conjunctivitis.
    Baddeley SM; Bacon AS; McGill JI; Lightman SL; Holgate ST; Roche WR
    Clin Exp Allergy; 1995 Jan; 25(1):41-50. PubMed ID: 7728624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased numbers of Langerhans cell and expression of HLA-Dr antigen in the giant papilla of patients with giant papillary conjunctivitis.
    Choi TH; Ko MK; Choe JK
    Korean J Ophthalmol; 1996 Jun; 10(1):18-23. PubMed ID: 8755197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The T cell receptor in normal and inflamed human conjunctiva.
    Soukiasian SH; Rice B; Foster CS; Lee SJ
    Invest Ophthalmol Vis Sci; 1992 Feb; 33(2):453-9. PubMed ID: 1531476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vernal keratoconjunctivitis with giant papillae on the inferior tarsal conjunctiva.
    Asada Y; Ebihara N; Funaki T; Yokoi N; Murakami A; Matsuda A
    Cornea; 2014 Jan; 33(1):32-4. PubMed ID: 24240487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increase in CD45RO+ cells and activated eosinophils in chronic allergic conjunctivitis.
    Di Gioacchino M; Cavallucci E; Di Sciascio MB; Di Stefano F; Verna N; Lobefalo L; Crudeli C; Volpe AR; Angelucci D; Cuccurullo F; Conti P
    Immunobiology; 2000 Apr; 201(5):541-51. PubMed ID: 10834312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A flow cytometric study about the immunopathology of vernal keratoconjunctivitis.
    Avunduk AM; Avunduk MC; Dayanir V; Tekelioglu Y; Dayioglu YS
    J Allergy Clin Immunol; 1998 Jun; 101(6 Pt 1):821-4. PubMed ID: 9648710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limbal vernal keratoconjunctivitis in the tropics.
    Tuft SJ; Cree IA; Woods M; Yorston D
    Ophthalmology; 1998 Aug; 105(8):1489-93. PubMed ID: 9709763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of Chemokines and a CD4-Positive T Cell Subset in the Development of Conjunctival Secondary Lymphoid Follicles in an Atopic Keratoconjunctivitis Mouse Model.
    Shoji J; Nakanishi Y; Ishimori A; Sakimoto T; Inada N; Nemoto N
    Int Arch Allergy Immunol; 2015; 167(3):147-57. PubMed ID: 26302769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes.
    Vichyanond P; Pacharn P; Pleyer U; Leonardi A
    Pediatr Allergy Immunol; 2014 Jun; 25(4):314-22. PubMed ID: 24438133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunopathology of atopic keratoconjunctivitis.
    Foster CS; Rice BA; Dutt JE
    Ophthalmology; 1991 Aug; 98(8):1190-6. PubMed ID: 1923355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-cell characterization in chronic allergic eye disease.
    Zhan H; Calder V; Lightman S
    Curr Allergy Asthma Rep; 2003 Jul; 3(4):358-62. PubMed ID: 12791216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases.
    Leonardi A; Borghesan F; Faggian D; Depaoli M; Secchi AG; Plebani M
    Am J Ophthalmol; 2000 Feb; 129(2):151-8. PubMed ID: 10682966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.